Billionaire Cliff Asness’ 5 New Stock Picks

4. Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)

AQR Capital Management’s Stake Value as of 9/30: $4,293,000

Percentage of AQR Capital Management’s 13F Portfolio as of 9/30: 0.01%

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) is a biotech company with a portfolio of products and product candidates with a focus in areas of neuroscience and oncology. In Q3, Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) reported adjusted EPS of $5.17 and revenue of $940.65 million vesus the consensus of $4.66 and $939.06 million. In the same quarter, AQR Capital Management established a new position of $4,293,000 in Jazz Pharmaceuticals Plc (NASDAQ:JAZZ).